CAR-T cell therapy has spread into earlier lines of care over the last ten years, going beyond heavily pretreated populations ...

CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.

A woman who had been sick for many years with three autoimmune conditions has experienced a remarkable recovery after being ...

This week on "The Readout LOUD," a pancreatic cancer breakthrough and new hope for an off-the-shelf CAR-T treatment in ...

For the first time, scientists have used a modern cell therapy called CAR-T to treat a patient with three different ...

A CAR-T cell therapy has successfully treated not one, not two, but three different autoimmune diseases at once in a patient, ...

The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.

Chimeric antigen receptor T-cell therapy (CAR T) has revolutionized oncology treatment over the last decade, offering targeted therapy options for several difficult cancers, espec ...

The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen ...

T-cell therapy is the most efficacious approach for many patients with relapsed/refractory multiple myeloma, but it currently comes with 2 periods ...

I f your doctor has recommended chimeric antigen receptor (CAR) T-cell immunotherapy for large B-cell lymphoma (LBCL), you’ve likely already tried several standard treatments, and the cancer did not ...

Mary Bird Perkins Cancer Center in Baton Rouge, Louisiana is offering a CAR-T cell-based immunotherapy, which genetically ...